The relationship between clinical symptoms of schizophrenia and acute drug-induced extrapyramidal disorders
Abstract
Studies are devoted to the clinical and biological phenomenology of acute drug-induced extrapyramidal disorders in schizophrenia. The article presents the results of studies of the association of clinical symptoms of schizophrenia with acute parkinsonism and akathisia, which resulted from the administration of standardized antipsychotic therapy to patients. It has been found that drug-induced akathisia is more reliably associated with such common psychopathological symptoms as anxiety, depression, affective lability, impaired control impairment, and active social exclusion. Drug-induced Parkinsonism revealed a relationship with negative symptoms, as well as motor retardation and violent impairment.
References
1. Jablensky A. (2000) Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry ClinNeurosci. Vol. 250, no. 6, pp. 274–285.
2. Gerlach J, Peacock L.(1995) New antipsychotics: the present status. In ClinPsychopharmacol. Vol. 10, pp. 39–48.
3. Steck H. (2006) Extrapyramidal and diencephalic syndrome in the course of largactil and serpasil treatments. Ann Med Psychol (Paris). Vol.12, pp.737–744.
4. Poyurovsky M (2010). Acute antipsychotic-induced akathisia revisited. Br J Psychiatry. Vol. 196, no. 2, pp. 89–91.
5. Плотникова Е. В. (2009) Лекарственно-индуцированные двигательные расстройства при шизофрении. Таврический медико-биологический вестник. Т. 12, № 1 (45). С. 192–199.
6. Sachdev P (2004) Early extrapyramidal side-effects as risk factors for later tardive dyskinesia: a prospective study. Aust N Z J Psychiatry. Vol. 38, no.6, pp. 445–9.
7. Duncan E. J., Adler L. A., Stephanides M. et al. (2000) Akathisia and exacerbation of psychopathology: a preliminary report. ClinNeuropharmacol. Vol. 23, pp. 169–173.
8. PeitlM. V., ProloščićJ., Blažević-ZelićS. (2011) Et al. Symptoms of agitated depression and/or akathisia. Psychiatr Danub. Vol. 23, no. 1, pp. 108–110.
9. Reid A. M., McNamara J. P, Murphy T. K. (2015) Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. J Psychiatr Res. Vol. 71, pp. 140–147.
10. Lipinski J. F. Jr., Mallya G., Zimmerman P. et al.(1989) Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry. Vol. 50, no. 9, pp. 339–342.
11. Temmingh H., Stein D. J. (2015) Anxiety in Patients with Schizophrenia: Epidemiology and Management. CNS Drugs. Vol. 29, no.10, pp. 819–832.
12. Kim JH, Byun HJ (2009). Non-motor cognitive-perceptual dysfunction associated with drug-induced parkinso-nism. Hum Psychopharmacol. Vol. 24, no. 2, pp. 129–134.
13. Kim JH, Kim SY, Byun HJ (2008). Subjective cognitive dysfunction associated with drug-induced parkinsonism in schizophrenia. Parkinsonism Relat. Disord. Vol. 14, no. 3, pp. 239–242.
14. Федорова Н. В., Ветохина Т. Н. (2009) Диагностика и лечение нейролептических экстрапирамидных синдромов. Псих. расстройства в общей медицине. – № 3.
15. Беккер Р. А., Быков Ю. В. Акатизия: клинический анализ патологии с рекомендациями и обзором литературы. Consilium Medicum: Публикации партнеров.
16. Berrios G. E. (1995) Lad Haskovec and akathisia: an introduction. Hist Psychiatry. Vol. 6, pp. 243–251
17. Mohr P., Volavka J. (2002) LadislavHaskovec and akathisia: 100th anniversary. Br J Psychiatry. Vol. 12, pp. 181–237.
18. Sachdev P. (1995) The development of the concept of akathisia: a historical overview. Schizophr Res. Vol. 16, no. 1, pp. 33–45.
19. Sachdev P (1995). The epidemiology of drug-induced akathisia: Part I. Acute akathisia. SchizophrBull. Vol. 21, no. 3, pp. 431–449. Availabe:http://psycnet.apa.org/psycinfo/1996–09010–001.
20. Sachdev P. (1995) The classification of akathisia. MovDisord. Vol. 10, no. 2, pp. 235–237.
21. Duncan E. J., Adler L. A., Stephanides M. et al. (2000) Akathisia and exacerbation of psychopathology: a preliminary report. ClinNeuropharmacol. Vol. 23, pp. 169–173.
22. PeitlM. V., Prološčić J., Blažević-Zelić S. etal. Symptoms of agitated depression and/or akathisia. PsychiatrDanub. Vol. 23, no. 1, pp. 108–110.
23. Левин О. С., Шиндряева Н. Н., Аникина М. А. (2012) Лекарственный паркинсонизм. Журнал неврологии и психиатрии им. С. С. Корсакова. № 8. – С. 69–74.
24. Nair C. J., Josiassen R. C., Abraham G. et al. Does akathisia influence psychopathology inpsychotic patients treated with clozapine? Biol Psychiatry. 1999; 45(10):1376–1383.
25. Peitl M. V., ProloščićJ., Blažević-ZelićS. Et al. (2010) Symptoms of agitated depression and/or akathisia. PsychiatrDanub. Vol. 23, no. 1, pp. 108–110.
26. Hardie RJ, Lees AJ (1988). Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J. Neurol. Neurosurg. Psychiatr. Vol. 51, no. 6, pp. 850–854.
27. Chouinard G, Ross-Chouinard A, Annable L, et al.: Extrapyramidal Rating Scale. The Canadian Journal of Neurological Sciences 7:233–239, 1980.
28. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13 (2): 261–76. PMID 3616518. doi:10.1093/schbul/13.2.261.
29. Lindenmayer, J. P. Five factor model of schizophrenia: Replication across samples / J. P. Lindenmayer, S. Grochowski, R. B. Hyman // Schizophr. Res. – 1995. – Vol. 14. – P. 229–234.
30. Barnes T. R. E., Liddle Evidense for the valibity of negative symptos. Scizophrenia: Positive and negative Symptoms and Syndroms. Modern Problems in Pharmacopsychiatry. Andreasen N. S., Kargen, Basel1990. vol. 24. p. 43–72.
31. Минутко В. Л. (2009) Шизофрения: монография. Курск, 2009, стр. 164–168.
32. Brüne M. The incidence of akathisia in bipolar affective disorder treated with neurolepticsa preliminary report (1999). J Affect Disord. Vol. 53, no. 2, pp. 175–177. Availabe: https://www.ncbi.nlm.nih.gov/pubmed/10360412.
33. Joukamaa M., Heliovaara M., Knekt P. (2006) Schizophrenia, neuroleptic medication and mortality. British Journal of Psychiatry. Vol. 188, рр. 122–127.
34. Stahl S. M., Lonnen A. J. The Mechanism of Druginduced Akathisia. CNS Spectr. 2011. pii:Stahl.
35. Lohr J. B., Eidt C. A., Abdulrazzaq Alfaraj A. et al. (2015) The clinical challenges of akathisia. CNS Spectr. Vol. 20, pp. 15–16 Availabe: https://www.ncbi.nlm.nih.gov/pubmed/26683525.
Review
For citations:
Gorgun O.V. The relationship between clinical symptoms of schizophrenia and acute drug-induced extrapyramidal disorders. Military Medicine. 2018;(1):14-20. (In Russ.)
Views:
56
JATS XML
Email this article 